Compare Nomura Holdings Inc (NMR) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nomura Holdings Inc vs TransMedics Group Inc — how do they compare? Nomura Holdings Inc trades at $9.4 (market cap $27.46B), while TransMedics Group Inc trades at $74.3 (market cap $2.54B). The key difference: Nomura Holdings Inc is far larger — about 10.8× TransMedics Group Inc's market cap, and Nomura Holdings Inc pays a 3.45% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.
| NMR | TMDX | |
|---|---|---|
Market Cap | $27.46B | $2.54B |
Sector | Financials | Technology |
52-Week High | $10.04 | $150.42 |
52-Week Low | $6.39 | $61.99 |
Dividend Yield | 3.45% | — |
Enterprise Value | — | $2.94B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nomura Holdings Inc
Nomura is Japan's largest broker, about twice the size of rival Daiwa Securities and roughly three times the size of the securities units of the three megabanks. It is also the largest asset-management company in Japan, with a similar size differential compared with its rivals. Despite its topnotch brand name in retail broking and asset management in Japan, Nomura has struggled to compete effectively in the institutional securities business against larger global rivals. In 2008, Nomura bought European and Asian assets of the failed Lehman Brothers, which led to a sharply higher cost base but did not provide commensurate revenue. Nomura has reduced the scale of these businesses but maintains its ambition to compete globally with the top players.
Read more on NMR →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
